Skip to main content

Advertisement

SpringerLink
Log in

Breast Cancer Management Updates: Young and Older, Pregnant, or Male

  • Breast Oncology
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Every year, more and more patients fall into rare or extreme categories of breast cancer—young, elderly, pregnant, or male. Contributing factors may be improved risk assessment and screening techniques (especially of dense breast tissue), delayed childbearing, and the aging population. These patients can challenge usual medical decision making because of their unique situation. There might be a concern for the fetus, worry about future fertility, a question of local control in a man, or concern for overdiagnosis or overtreatment in an older patient. Because these populations are seldom included in the large breast cancer trials from which standard treatment recommendations are made, an update on management for young, elderly, pregnant, and male breast cancer patients may be helpful.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. American Cancer Society. Breast cancer facts and figures, 2013–2014. Atlanta: American Cancer Society; 2013.

    Google Scholar 

  2. DeSantis C, Ma J, Bryan L, Jemal A. Breast cancer statistics, 2013. CA Cancer J Clin. 2014;64:52–62.

    Article  PubMed  Google Scholar 

  3. Partridge AH, Hughes ME, Ottesen RA, et al. The effect of age on delay in diagnosis and stage of breast cancer. Oncologist. 2012;17:775–82.

    Article  PubMed Central  PubMed  Google Scholar 

  4. Keegan TH, DeRouen MC, Press DJ, Kurian AW, Clarke CA. Occurrence of breast cancer subtypes in adolescent and young adult women. Breast Cancer Res. 2012;14:R55.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  5. Arvold ND, Taghian AG, Niemierko A, et al. Age, breast cancer subtype approximation, and local recurrence after breast-conserving therapy. J Clin Oncol. 2011;29:3885–91.

    Article  PubMed Central  PubMed  Google Scholar 

  6. Partridge AH, Gelber S, Piccart-Gebhart MJ, et al. Effect of age on breast cancer outcomes in women with human epidermal growth factor receptor 2–positive breast cancer: results from a herceptin adjuvant trial. J Clin Oncol. 2013;31:2692–8.

    Article  CAS  PubMed  Google Scholar 

  7. Ruddy KJ, Gelber SI, Tamimi RM, et al. Prospective study of fertility concerns and preservation strategies in young women with breast cancer. J Clin Oncol. 2014;32:1151–6.

    Article  PubMed Central  PubMed  Google Scholar 

  8. Loren AW, Mangu PB, Beck LN, et al. Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2013;31:2500–10.

    Article  PubMed  Google Scholar 

  9. Robson ME, Storm CD, Weitzel J, Wollins DS, Offit K; American Society of Clinical Oncology. American Society of Clinical Oncology policy statement update: genetic and genomic testing for cancer susceptibility. J Clin Oncol. 2010;28:893–901.

    Article  PubMed  Google Scholar 

  10. Shapira M, Raanani H, Meirow D. IVF for fertility preservation in breast cancer patients—efficacy and safety issues. Curr Treat Options Oncol. 2015;16:16.

    Article  Google Scholar 

  11. Lambertini M, Ginsburg E, Partridge A. Update on fertility preservation in young women undergoing breast cancer and ovarian cancer therapy. Curr Opin Obstet Gynecol. 2015;27:98–107.

    Article  PubMed  Google Scholar 

  12. Howard-Anderson J, Ganz PA, Bower JE, Stanton AL. Quality of life, fertility concerns, and behavioral health outcomes in younger breast cancer survivors: a systematic review. J Natl Cancer Inst. 2012;104:386–405.

    Article  PubMed  Google Scholar 

  13. Kurian AW, Lichtensztajn DY, Keegan TH, Nelson DO, Clarke CA, Gomez SL. Use of and mortality after bilateral mastectomy compared with other surgical treatments for breast cancer in California, 1998–2011. JAMA. 2014;312:902–14.

    Article  CAS  PubMed  Google Scholar 

  14. Hawley ST, Jagsi R, Morrow M, Janz NK, Hamilton A, Graff JJ, Katz SJ. Social and clinical determinants of contralateral prophylactic mastectomy. JAMA Surg. 2014. doi:10.1001/jamasurg.2013.5689.

    Google Scholar 

  15. Goldhirsch A, Winer EP, Coates AS, et al. Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer, 2013. Ann Oncol. 2013;24:2206–23.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  16. Francis PA, Regan MM, Fleming GF, et al. Adjuvant ovarian suppression in premenopausal breast cancer. N Engl J Med. 2015;372:436–46.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  17. Davies C, Pan H, Godwin J, et al. Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial. Lancet. 2013;381:805–16.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  18. Nelson HD, Tyne K, Naik A, Bougatsos C, Chan BK, Humphrey L; US Preventive Services Task Force. Screening for breast cancer: an update for the US Preventive Services Task Force. Ann Intern Med. 2009;151:727–37.

    Article  PubMed Central  PubMed  Google Scholar 

  19. American Cancer Society. Estimated new cancer cases by sex and age (years), 104. http://www.cancer.org/acs/groups/content/@research/documents/document/acspc-041776.pdf.

  20. Badgwell BD, Giordano SH, Duan ZZ, et al. Mammography before diagnosis among women age 80 years and older with breast cancer. J Clin Oncol. 2008;26:2482–8.

    Article  PubMed  Google Scholar 

  21. US Center for Disease Control and Prevention. Vital statistics of the United States, 1995. May 1998. http://www.cdc.gov/nchs/data/lifetables/life95_2.pdf.

  22. McCarthy EP, Burns RB, Freund KM, et al. Mammography use, breast cancer stage at diagnosis, and survival among older women. J Am Geriatr Soc. 2000;48:1226–33.

    Article  CAS  PubMed  Google Scholar 

  23. Schonberg MA, Marcantonio ER, Ngo L, Li D, Silliman RA, McCarthy EP. Causes of death and relative survival of older women after a breast cancer diagnosis. J Clin Oncol. 2011;29:1570–7.

    Article  PubMed Central  PubMed  Google Scholar 

  24. McPherson CP, Swenson KK, Lee MW. The effects of mammographic detection and comorbidity on the survival of older women with breast cancer. J Am Geriatr Soc. 2002;50:1061–8.

    Article  PubMed  Google Scholar 

  25. Walter LC, Lindquist K, Covinsky KE. Relationship between health status and use of screening mammography and Papanicolaou smears among women older than 70 years of age. Ann Intern Med. 2004;140:681–8.

    Article  PubMed  Google Scholar 

  26. Schonberg MA, Davis RB, McCarthy EP, Marcantonio ER. Index to predict 5-year mortality of community-dwelling adults aged 65 and older using data from the National Health Interview Survey. J Gen Intern Med. 2009;24:1115–22.

    Article  PubMed Central  PubMed  Google Scholar 

  27. Mislang AR, Biganzoli L. Adjuvant systemic therapy in older breast cancer women: can we optimize the level of care? Cancers (Basel). 2015;7:1191–214.

    Article  PubMed  Google Scholar 

  28. Hughes KS, Schnaper LA, Bellon JR, et al. Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343. J Clin Oncol. 2013;31:2382–7.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  29. Kunkler IH, Williams LJ, Jack WJ, Cameron DA, Dixon JM; PRIME II Investigators. Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIMEII): a randomized controlled trial. Lancet Oncol. 2015;16:266–73.

    Article  PubMed  Google Scholar 

  30. Rutter CE, Lester-Coll NH, Mancini BR, et al. The evolving role of adjuvant radiotherapy for elderly women with early-stage breast cancer. Cancer. 2015;121:2331–40.

    Article  CAS  PubMed  Google Scholar 

  31. Lambertini M, Kamal NS, Peccatori FA, Del Mastro L, Azim HA Jr. Exploring the safety of chemotherapy for treating breast cancer during pregnancy. Expert Opin Drug Saf. 2015;29:1–14.

    Article  Google Scholar 

  32. Cardonick E. Pregnancy associated breast cancer: optimal treatment options. Int J Womens Health. 2014;6:935–43.

    Article  PubMed Central  PubMed  Google Scholar 

  33. Gropper AB, Calvillo KZ, Dominici L, et al. Sentinel lymph node biopsy in pregnant women with breast cancer. Ann Surg Oncol. 2014;21:2506–11.

    Article  PubMed  Google Scholar 

  34. Spanheimer PM, Graham MM, Sugg SL, Scott-Conner CEH, Weigel RJ. Measurement of uterine radiation exposure from lymphoscintigraphy indicates safety of sentinel lymph node biopsy during pregnancy. Ann Surg Oncol. 2009;16:1143–7.

    Article  PubMed  Google Scholar 

  35. Cardonick E, Doughtery R, Grana G, Gilmandyar D, Ghaffar S, Usmani A. Breast cancer during pregnancy: maternal and fetal outcomes. Cancer J. 2010;16:76–82.

    Article  PubMed  Google Scholar 

  36. Zagouri F, Sergentanis TN, Chrysikos D, Papadimitriou CA, Dimopoulos MA, Bartsch R. Trastuzumab administration during pregnancy: a systematic review and meta-analysis. Breast Cancer Res Treat. 2013;137:349–57.

    Article  CAS  PubMed  Google Scholar 

  37. Korde LA, Zujewski JA, Kamin L, et al. Multidisciplinary meeting on male breast cancer: summary and research recommendations. J Clin Oncol. 2010;28:2114–22.

    Article  PubMed Central  PubMed  Google Scholar 

  38. Ruddy KJ, Winer EP. Male breast cancer: risk factors, biology, diagnosis, treatment, and survivorship. Ann Oncol. 2013;24:1434–43.

    Article  CAS  PubMed  Google Scholar 

  39. Cardoso F, Bartlett J, Slaets L, et al. Characterization of male breast cancer: first results of the EORTC10085/TBCRC/BIG/NABCG International Male Breast Cancer Program [abstract S6-05]. Paper presented at: 2014 San Antonio Breast Cancer Symposium; 12 Dec 2014.

  40. Male breast cancer: understanding the biology for improved patient care. http://www.cancer.gov/clinicaltrials/search/view?cdrid=669240&version=HealthProfessional. Accessed 8 March 2015.

  41. Kiluk JV, Lee MC, Park CK, et al. Male breast cancer: management and follow-up recommendations. Breast J. 2011;17:503–9.

    Article  PubMed  Google Scholar 

  42. NCCN Clinical Practice Guidelines in Oncology. Genetic/familial high-risk assessment: breast and ovarian cancer, v.2.2014. http://www.nccn.org. Accessed 9 March 2015.

  43. Basham VM, Lipscombe JM, Ward JM, et al. BRCA1 and BRCA2 mutations in a population-based study of male breast cancer. Breast Cancer Res. 2002;4:R2.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  44. Couch FJ, Farid LM, DeShano ML, et al. BRCA2 germline mutations in male breast cancer cases and breast cancer families. Nat Genet. 1996;13:123–5.

    Article  CAS  PubMed  Google Scholar 

  45. Ding YC, Steele L, Kuan CJ, Greilac S, Neuhausen SL. Mutations in BRCA2 and PALB2 in male breast cancer cases from the United States. Breast Cancer Res Treat. 2011;126:771–8.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  46. Friedman LS, Gayther SA, Kurosaki T, et al. Mutation analysis of BRCA1 and BRCA2 in a male breast cancer population. Am J Hum Genet. 1997;60:313–9.

    PubMed Central  CAS  PubMed  Google Scholar 

  47. Fields EC, DeWitt P, Fisher CM, Rabinovitch R. Management of male breast cancer in the United States: a surveillance, epidemiology and end results analysis. Int J Radiat Oncol Biol Phys. 2013;87:747–52.

    Article  PubMed  Google Scholar 

  48. Al-Kalla T, Komorowska-Timek E. Breast total male breast reconstruction with fat grafting. Plast Reconstr Surg Glob Open. 2014;2:e257.

    Article  PubMed Central  PubMed  Google Scholar 

  49. Golshan M, Rusby J, Dominguez F, Smith BL. Breast conservation for male breast carcinoma. Breast. 2007;16:653–6.

    Article  PubMed  Google Scholar 

  50. Boughey JC, Bedrosian I, Meric-Bernstam F, et al. Comparative analysis of sentinel lymph node operation in male and female breast cancer patients. J Am Coll Surg. 2006;203:475–80.

    Article  PubMed  Google Scholar 

  51. Flynn LW, Park J, Patil SM, Cody HS 3rd, Port ER. Sentinel lymph node biopsy is successful and accurate in male breast carcinoma. J Am Coll Surg. 2008;206:616–21.

    Article  PubMed  Google Scholar 

  52. Grenader T, Yerushalmi R, Tokar M, Fried G, Kaufman B, Peretz T, Geffen DB. The 21-gene recurrence score assay (Oncotype DX) in estrogen receptor–positive male breast cancer: experience in an Israeli cohort. Oncology. 2014;87:1–6.

    Article  CAS  PubMed  Google Scholar 

  53. Eggemann H, Ignatov A, Smith BJ, et al. Adjuvant therapy with tamoxifen compared to aromatase inhibitors for 257 male breast cancer patients. Breast Cancer Res Treat. 2013;137:465–70.

    Article  CAS  PubMed  Google Scholar 

  54. Gnerlich JL, Deshpande AD, Jeffe DB, Seelam S, Kimbuende E, Margenthaler JA. Poorer survival outcomes for male breast cancer compared with female breast cancer may be attributable to in-stage migration. Ann Surg Oncol. 2011;18:1837–44.

    Article  PubMed Central  PubMed  Google Scholar 

  55. Shin JY, Kachnic LA, Hirsch AE. The impact of race in male breast cancer treatment and outcome in the United States: a population-based analysis of 4279 patients. Int J Breast Cancer. 2014;2014:685842.

    Article  PubMed Central  PubMed  Google Scholar 

Download references

Disclosure

The authors declare no conflict of interest.

Author information

Authors and Affiliations

  1. Case Western Reserve School of Medicine, Cleveland, USA

    Jill R. Dietz MD

  2. Dana-Farber Cancer Institute, Boston, USA

    Ann H. Partridge MD, MPH

  3. Memorial Sloan Kettering Cancer Center, New York, USA

    Mary L. Gemignani MD, MPH

  4. University of Washington, Seattle, USA

    Sara H. Javid MD

  5. MD Anderson Cancer Center, Houston, USA

    Henry M. Kuerer MD, PhD

Authors
  1. Jill R. Dietz MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ann H. Partridge MD, MPH
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mary L. Gemignani MD, MPH
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Sara H. Javid MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Henry M. Kuerer MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jill R. Dietz MD.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dietz, J.R., Partridge, A.H., Gemignani, M.L. et al. Breast Cancer Management Updates: Young and Older, Pregnant, or Male. Ann Surg Oncol 22, 3219–3224 (2015). https://doi.org/10.1245/s10434-015-4755-1

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-015-4755-1

Keywords

Search

Navigation